info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Global Atherectomy Devices Market worth $2.02 billion in 2030

Global Atherectomy Devices Market worth $2.02 billion in 2030


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report ‘Global Atherectomy Devices Market by Type (directional, rotational, orbital and laser atherectomy), application (peripheral vascular, cardiovascular, neurovascular applications), end-user (hospitals and surgical centres, ambulatory care centres, other end users), and region (North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa) – Global Forecast to 2030’. In 2020, the Global Atherectomy Devices Market was valued at $0.99 billion and was expected to grow to $2.02 billion in 2030 at a CAGR of 7.34%.

global atherectomy devices market 2020-2030

To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/atherectomy-devices-market

 

Key Factors Augmenting the Market Growth

Some of the critical factors that assist in driving the market forward are the rise in prevalence of diseases and the geriatric population, preference for minimally invasive surgical procedures and high success rate.

 

By type, the ‘orbital atherectomy’ segment held the maximum share of 30% in 2020

Orbital atherectomy is an adjunctive technique used for the lesion preparation of calcified plaque to avoid percutaneous coronary and peripheral percutaneous endovascular interventions. This is a popular technique that accelerates the market growth. The laser atherectomy segment is expected to grow the fastest with a CAGR of 7%. On the other hand, the directional atherectomy market segment held the maximum share in 2018.

 

By application, the ‘peripheral vascular applications’ segment is expected to grow at the fastest, rate with a 6.71% CAGR.

NCBI has conducted a study in which it observed that more than 200 million people around the world have peripheral artery disease (PAD). As a result, atherectomy has been increasingly accepted for treating cardiac and peripheral vascular conditions, which is expected to increase the growth of the peripheral vascular applications segment.

 

By end-user, the ‘hospitals and surgical centre segment is expected to have the fastest market growth rate, with more than 6.63% CAGR.

The availability of trained professionals and the increase in acceptability and demand for atherectomy to treat cardiac and peripheral vascular diseases have accelerated market growth in this segment. 

 

By region, ‘Asia-Pacific’ is expected to have the highest market growth rate, with a CAGR of 8.2%

In the Asia-Pacific region, socio-economic changes, unhealthy diet, liquor diet, smoking, and demographic ageing have increased target diseases among the population, increasing the demand for atherectomy devices and thereby accelerating market growth. The North American region held the maximum market revenue share in 2016 due to increased R&D spending and the increased availability of trained professionals and infrastructure.

 

Key Market Leaders

The major competitors in the Global Atherectomy Devices Market are Abbott Laboratories, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company (BD Interventional), Koninklijke Philips N.V., Avinger, Inc., Rex Medical and AngioDynamics.

 

Recent Developments

  • In April 2022, AngioDynamics, Inc. announced a study to assess the use of its Auryon Atherectomy system to treat calcified lesions below the knee arteries. If successful, the Auryon Atherectomy System could reduce the risk of perforation and preserve the ability to vaporise lesions without thermal ablations.
  • In November 2021, Royal Philips announced the launch of its Nexcimer system. The Nexcimer system will treat peripheral and coronary diseases and perform lead extraction procedures using atherectomy.
  • In January 2021, Boston Scientific announced a limited market release of the WaveWriter Alpha portfolio of the Spinal Cord Simulator systems. The SCS and the Fast-Acting Sub-perception Therapy systems are designed to provide uncompromised personalisation and intense pain relief within minutes for a patient, improving the market growth rate.
  • In January 2021, Cardiovascular Systems, Inc. received CE Mark for its Diamondback 360 Coronary Orbital Atherectomy System. The system combines sanding and pulsating forces to treat nodular, eccentric, and concentric calcium modalities.
  • In March 2020, Straub Medical LLC (a Becton, Dickinson and Company subsidiary) announced the launch and first intervention performed with the Rotarex S atherectomy device. The device is used to treat occlusive peripheral vascular disease in both the upper and lower extremity arteries.

Choose License Type



$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved